Understanding the effects of Myc on lung cancer immune signaling in vitro and in vivo
Understanding the effect of Myc on lung cancer immune signalling in vitro and in vivo Immune checkpoint blockade therapy (ICBT) is a promising treatment option that is commonly used for advanced non-small cell lung cancer (NSCLC). Immune checkpoint inhibitors targeting the PD-1/PD-L1 interaction have demonstrated remarkable effects. Blocking the PD-1/PD-L1 axis restores tumor cell recognition and
